How the $2,000 Drug Cap Saves Medicare Retirees This Year
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
In need of cash assistance? Explore various ways to secure quick cash to help you through tough financial times.
21,137 articlesMedicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
A top Interface executive dumped stock in a move worth hundreds of thousands. Is this a signal about the business or ...
Rocket Lab faces a pivotal Q1 print this evening as analysts weigh Neutron timing against a record backlog. Guidance ...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Retirees who start Social Security early and continue working may see withheld benefits restored later. The earnings ...
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
The IPO market is shifting in 2026, and smart investors are turning to robo-advisors to balance access and risk. Lear...
A landmark deal sent Dominion Energy stock jumped after NextEra Energy offered a stock-for-stock combination. This ar...
A multi-decade rally faces a valuation crossroads as the CAPE gauge sits near historic highs. Here’s how years market...
JPMorgan Chase CEO Jamie Dimon warns that markets may be riding an exuberant wave around AI and Big Tech, signaling ...